PTX3 and D-dimer in children with asthma: A real-world study-Reply
- 1 April 2019
- journal article
- letter
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 49 (4) , 552
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pentraxin 3 deletion aggravates allergic inflammation through a TH17-dominant phenotype and enhanced CD4 T-cell survivalJournal of Allergy and Clinical Immunology, 2017
- Prothrombotic state in patients with severe and prednisolone-dependent asthmaJournal of Allergy and Clinical Immunology, 2016
- Asthma increases pulmonary thromboembolism risk: a nationwide population cohort studyEuropean Respiratory Journal, 2013
- Risk of deep vein thrombosis and pulmonary embolism in asthmaEuropean Respiratory Journal, 2012
- Pentraxin 3 (PTX3) Expression in Allergic Asthmatic Airways: Role in Airway Smooth Muscle Migration and Chemokine ProductionPLOS ONE, 2012
- Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroidsThorax, 2009
- PENTRAXINS AT THE CROSSROADS BETWEEN INNATE IMMUNITY, INFLAMMATION, MATRIX DEPOSITION, AND FEMALE FERTILITYAnnual Review of Immunology, 2005